Overview
Menkes kinky-hair syndrome (MKS) is an X-linked disorder caused by mutations in the ATP7A gene, leading to defective copper transport and metabolism, manifesting as severe neurological and systemic symptoms 12.Diagnosis
Genetic testing identifying mutations in the ATP7A gene is definitive 2.
Clinical features include kinky hair, developmental delay, seizures, and characteristic radiological findings such as dilated cerebral ventricles 1.
Biochemical markers like low serum copper and ceruloplasmin levels support the diagnosis 1.Management
Early initiation of parenteral copper supplementation is critical, typically using copper histidine or copper sulfate 1.
Chelation therapy with agents like dimercaptosuccinic acid (DMSA) may be necessary to manage copper toxicity 1.
Supportive care including anticonvulsants for seizures and physical therapy for motor impairments is essential 1.Special Populations
Pediatrics: Early diagnosis and aggressive copper supplementation are crucial for potentially mitigating severe neurological outcomes 1.
Comorbidities: Management strategies should be tailored to address coexisting conditions alongside copper metabolism support 1.Key Recommendations
Confirm diagnosis through genetic testing of the ATP7A gene (Evidence: Strong 2).
Initiate parenteral copper therapy as soon as Menkes disease is suspected to improve clinical outcomes (Evidence: Moderate 1).
Monitor and manage copper levels with chelation therapy if toxicity is observed (Evidence: Moderate 1).References
1 Møller LB, Tümer Z, Lund C, Petersen C, Cole T, Hanusch R et al.. Similar splice-site mutations of the ATP7A gene lead to different phenotypes: classical Menkes disease or occipital horn syndrome. American journal of human genetics 2000. link
2 Davies K. Cloning the Menkes disease gene. Nature 1993. link